10 Key Factors That Elevate Your Risk of Merkel Cell Carcinoma
8. Long-Term PUVA Therapy: A Past Treatment's Lingering Shadow

For individuals who underwent extensive PUVA (Psoralen plus Ultraviolet A) therapy, historically used for severe psoriasis or other skin conditions, a lingering risk for MCC exists. PUVA combines a photosensitizing drug (psoralen) with UVA radiation, a potent combination that can cause significant DNA damage in skin cells over time, increasing the likelihood of various skin malignancies. While less common now due to newer treatments, a history of high-dose or prolonged PUVA exposure warrants ongoing skin surveillance for MCC and other skin cancers.